Zepp Health Corporation

ZEPP

Consumer Electronics · Technology

Price

$5.26

-0.04 (-0.75%)

Market Cap

$75.3M

Exchange

New York Stock Exchange

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 27, 2026 · filings through Mar 31, 2026

How the score breaks down

Quality

Weak

Growth

Mixed

Cash Flow

Weak

Stability

Weak

Valuation

Data not available

Track this stock — start free trial

Share count falling — buybacks

−94.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 16.5M (2021) → 994K (2025)

Winston Score History

The full picture

Zepp Health makes smartwatches and fitness bands that track things like heart rate, sleep, and exercise. Its main brand is Amazfit, and it also makes components for Xiaomi's Mi Band line. The company sells to health-conscious consumers looking for affordable wearable devices.

Zepp Health earns money by selling hardware — mainly smartwatches and fitness trackers — through online and retail channels worldwide. The company is headquartered in China and operates globally, though it is small with a market cap around $100 million. Its competitive edge has been offering feature-rich wearables at lower prices than Apple or Samsung, but intense competition and its negative operating margins pose significant risks to long-term profitability.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+27.1% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

R&D Spend

¥318M/ year

↓ Declining (-6% vs prior year)

17.5% of revenue

In line with sector average (15%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

¥2.2B cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Strong grower

Zepp Health Corporation is growing revenue at 27% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

38.7%

Modest — 38.7% gross margin

Profit after running costs

Operating Margin

-34.3%

Losing money on operations — -34.3%

Return on the money invested

ROCE

-6.7%

Weak — -6.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+47.1%

Fast-growing sales (+47.1% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-9.6%

Burning cash (-9.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.23

Elevated debt (1.23)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial